New treatments to tackle pandemic of drug-resistant infections

New treatments to tackle pandemic of drug-resistant infections New treatments to tackle drug-resistant infections that pose the greatest threat to global health are to be developed following a multi-million-pound investment by the UK government.

Antimicrobial resistance (AMR) – where serious infections have evolved so much that antibiotics and other current treatments are no longer effective – is a silent killer costing millions of lives across the world a year, with one in five of these deaths in children under the age of 5. Department of Health and Social Care